We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$414M
AUM Growth
+$142M
Cap. Flow
+$137M
Cap. Flow %
33.08%
Top 10 Hldgs %
55.2%
Holding
74
New
15
Increased
11
Reduced
28
Closed
14

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$7.74M
2
UNH icon
UnitedHealth
UNH
+$7.22M
3
PFE icon
Pfizer
PFE
+$6.28M
4
THC icon
Tenet Healthcare
THC
+$3.92M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.28M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$7.06M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.08M
3
VTRS icon
Viatris
VTRS
+$4.25M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$4.14M
5
BIIB icon
Biogen
BIIB
+$3.55M

Sector Composition

Rank Sector Weight
1 Healthcare 58.08%
2 Energy 0.72%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRFS
51
Grifois
GRFS
$5.46B
$2.11M 0.51%
+100,020
New +$1.91M
TDOC icon
52
Teladoc Health
TDOC
$1.25B
$1.99M 0.48%
+30,000
New +$1.75M
AKRX
53
DELISTED
Akorn Inc
AKRX
$1.96M 0.47%
380,000
+14,300
+4% +$55K
NVRO
54
DELISTED
NEVRO CORP.
NVRO
$1.95M 0.47%
30,000
-20,000
-40% -$1.25M
RVTY icon
55
Revvity
RVTY
$13B
$1.93M 0.47%
+20,000
New +$1.86M
ILMN icon
56
Illumina
ILMN
$29B
$1.84M 0.45%
5,140
-7,710
-60% -$2.43M
HRC
57
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.57M 0.38%
+15,000
New +$1.52M
AGIO icon
58
Agios Pharmaceuticals
AGIO
$1.97B
$1.5M 0.36%
30,000
+5,000
+20% +$267K
ACAD icon
59
Acadia Pharmaceuticals
ACAD
$5.08B
$1.34M 0.32%
+50,000
New +$1.28M
ABBV icon
60
AbbVie
ABBV
$443B
– –
-42,500
Closed -$3.42M
BIIB icon
61
Biogen
BIIB
$30.4B
– –
-15,000
Closed -$3.55M
DXCM icon
62
DexCom
DXCM
$33.5B
– –
-50,000
Closed -$1.49M
FMS icon
63
Fresenius Medical Care
FMS
$12.8B
– –
-50,000
Closed -$2.03M
NVO
64
Novo Nordisk
NVO
$207B
– –
-270,000
Closed -$7.06M
PBYI icon
65
Puma Biotechnology
PBYI
$454M
– –
-40,000
Closed -$1.55M
PRGO icon
66
Perrigo
PRGO
$1.76B
– –
-40,000
Closed -$1.93M
QGEN icon
67
Qiagen
QGEN
$8.89B
– –
-75,444
Closed -$3.25M
TEVA icon
68
Teva Pharmaceuticals
TEVA
$42.5B
– –
-215,000
Closed -$3.37M
VTRS icon
69
Viatris
VTRS
$18.8B
– –
-150,000
Closed -$4.25M
ALXN
70
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-45,000
Closed -$6.08M
VAR
71
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-19,000
Closed -$2.69M
EAS
72
DELISTED
ENERGY EAST CORP (HOLD CO)
EAS
– –
-20,000
Closed -$1.73M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return

Sivik Global Healthcare's Q2 2019 Portfolio in Review

As of Q2 2019, Sivik Global Healthcare held 74 positions worth $414M, up 52% from $271M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sivik Global Healthcare deployed $137M of net new capital in Q2 2019, opening 15 new positions and adding to 11 existing holdings. Its largest new stake was Becton Dickinson: 33,313 shares worth $8.19M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 93% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $4.14M trimmed.

  • Sivik Global Healthcare's largest Q2 2019 buy was Becton Dickinson: 33,313 shares worth $8.19M.
  • Sivik Global Healthcare added most to Edwards Lifesciences in Q2 2019, an estimated $2.72M increase.
  • Sivik Global Healthcare's biggest Q2 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $4.14M.
  • Sivik Global Healthcare fully exited Novo Nordisk in Q2 2019, selling an estimated $7.06M.
  • Sivik Global Healthcare's ten largest holdings make up 55% of its $414M portfolio in Q2 2019.
  • Sivik Global Healthcare opened 15 new positions and closed 14 in Q2 2019.
  • Sivik Global Healthcare's portfolio value rose 52% quarter-over-quarter to $414M.

Based on Sivik Global Healthcare's 13F filing for Q2 2019, filed 14 Aug 2019.